1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behr, JP; Boeckler, C; Boussif, O; Frisch, B; Kichler, A; Remy, JS; Schuber, F | 1 |
| Cossu, F; Melis, G; Rombi, G | 1 |
2 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Liver Neoplasms
| Article | Year |
|---|---|
Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipids.
Topics: 3T3 Cells; Animals; Gene Transfer Techniques; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Phosphatidylethanolamines; Spermine; Sulfhydryl Reagents; Transfection; Tumor Cells, Cultured | 1995 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |